Iwama, Noriyuki
Izumi, Seiya
Nobayashi, Hiroki
Murakami, Takahisa
Satoh, Michihiro
Tomita, Hasumi
Hamada, Hirotaka
Ishikuro, Mami
Obara, Taku
Saito, Masatoshi
Ohkubo, Takayoshi
Kuriyama, Shinichi
Hoshi, Kazuhiko
Imai, Yutaka
Metoki, Hirohito
,
Article History
Received: 22 August 2025
Revised: 4 October 2025
Accepted: 15 October 2025
First Online: 20 November 2025
Compliance with ethical standards
:
: Omron Healthcare Co., Ltd. was not involved in the study design, statistical analysis, or the writing of the manuscript. The Division of Integrative Renal Replacement Therapy (T.H.) is financially supported by JMS Co., Ltd.; Terumo Corporation; and Southern TOHOKU Hospital Group (STHG). Takayoshi Ohkubo has received honoraria for lectures from Omron Healthcare Co., Ltd. Michihiro Satoh received a scholarship donation (Academic support program) from Bayer Yakuhin Co., Ltd. Hirohito Metoki holds a registered patent related to other research themes associated with the present study.